At the conference, first-ever accuracy and performance data will be presented for Dexcom’s upcoming G7 15 Day system,1 ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of $98.00. The ...

Dexcom (Nadsaq:DXCM) announced today that it launched a new multi-region report evaluating type 2 diabetes treatments.

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

A survey conducted by the continuous glucose monitor maker Dexcom found that just over half of healthcare providers ranked ...

Analysts at William Blair reduced their Q1 2025 earnings estimates for shares of DexCom in a research note issued to ...

DexCom, Inc. (NASDAQ:DXCM), founded in 1999 ... DXCM but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

Dexcom, a medical device manufacturer that develops continuous glucose monitoring systems, received a warning letter from the FDA regarding manufacturing processes at its facilities in San Diego and ...

DexCom said that on Tuesday it received a warning letter from the U.S. FDA following inspections at its facilities in San Diego, Calif., and Mesa, Ariz. related to concerns about manufacturing ...

Shares of DexCom Inc. DXCM slid 2.10% to $77.84 Friday, on what proved to be an all-around great trading session for the ...

At the conference, first-ever accuracy and performance data will be presented for Dexcom’s upcoming G7 15 Day system, 1 showing an overall mean absolute relative difference (MARD) of 8.0% ...